Nutraceutical use in late-stage cancer

Michael J. Wargovich, Jay Morris, Vondina Brown, Jane Ellis, Britt Logothetis, Rebecca Weber

Resultado de la investigación: Review articlerevisión exhaustiva

31 Citas (Scopus)


Access to a wealth of information on the internet has led many cancer patients to use complementary methods as an adjunct to traditional therapy for cancer, with, and more often, without informing their primary caregiver. Of the common complementary modalities, the use of dietary supplements appears to be highly prevalent in patients in active treatment for cancer, and later in cancer survivors. Emerging research suggests that some plant-based agents may, indeed, impact late-stage cancer, influencing molecular processes corrupted by tumor cells to evade detection, expand clonally, and invade surrounding tissues. The intent of this article is to review some of the current science underpinning the use of nutraceuticals in the latter stages of cancer.

Idioma originalEnglish (US)
Páginas (desde-hasta)503-510
Número de páginas8
PublicaciónCancer and Metastasis Reviews
EstadoPublished - sept 2010
Publicado de forma externa

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Profundice en los temas de investigación de 'Nutraceutical use in late-stage cancer'. En conjunto forman una huella única.

Citar esto